baclofen has been researched along with Anemia, Hemolytic, Congenital in 1 studies
Anemia, Hemolytic, Congenital: Hemolytic anemia due to various intrinsic defects of the erythrocyte.
| Excerpt | Relevance | Reference |
|---|---|---|
| "When selegiline was stopped after 9 years of treatment, abnormal involuntary movements improved to pretreatment level and psychiatric behaviour returned to normal." | 1.32 | Adverse effects of dopamine potentiation by long-term treatment with selegiline. ( Hollán, S; Magyar, K; Vécsei, L, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hollán, S | 1 |
| Vécsei, L | 1 |
| Magyar, K | 1 |
1 other study available for baclofen and Anemia, Hemolytic, Congenital
| Article | Year |
|---|---|
Adverse effects of dopamine potentiation by long-term treatment with selegiline.
Topics: Adolescent; Adult; Anemia, Hemolytic, Congenital; Antiparkinson Agents; Baclofen; Basal Ganglia; Bas | 2004 |